[HTML][HTML] Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
ME Mehrabadi, R Hemmati, A Tashakor… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of COVID-19, is
reported to increase the rate of mortality worldwide. COVID-19 is associated with acute …
reported to increase the rate of mortality worldwide. COVID-19 is associated with acute …
Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists
AA de Oliveira, A Vergara, X Wang, JC Vederas… - Peptides, 2022 - Elsevier
The apelin/apelin receptor (ApelinR) signal transduction pathway exerts essential biological
roles, particularly in the cardiovascular system. Disturbances in the apelin/ApelinR axis are …
roles, particularly in the cardiovascular system. Disturbances in the apelin/ApelinR axis are …
[HTML][HTML] A comprehensive review of the neurobehavioral effects of bisphenol S and the mechanisms of action: New insights from in vitro and in vivo models
The normal brain development and function are delicately driven by an ever-changing
milieu of steroid hormones arising from fetal, placental, and maternal origins. This reliance …
milieu of steroid hormones arising from fetal, placental, and maternal origins. This reliance …
The Elabela-APJ axis: a promising therapeutic target for heart failure
Z Ma, JJ Song, S Martin, XC Yang, JC Zhong - Heart Failure Reviews, 2021 - Springer
Heart failure (HF) is a growing epidemic with high morbidity and mortality at an international
scale. The apelin–APJ receptor pathway has been implicated in HF, making it a promising …
scale. The apelin–APJ receptor pathway has been implicated in HF, making it a promising …
The therapeutic potentials of apelin in obesity-associated diseases
I Castan-Laurell, C Dray, P Valet - Molecular and Cellular Endocrinology, 2021 - Elsevier
Apelin, a peptide with several active isoforms ranging from 36 to 12 amino acids and its
receptor APJ, a G-protein-coupled receptor, are widely distributed. However, apelin has …
receptor APJ, a G-protein-coupled receptor, are widely distributed. However, apelin has …
Neuroprotective gain of Apelin/APJ system
JX Zhou, NN Shuai, B Wang, X Jin, X Kuang, SW Tian - Neuropeptides, 2021 - Elsevier
Apelin is an endogenous ligand of G protein-coupled receptor APJ. In recent years, many
studies have shown that the apelin/APJ system has neuroprotective properties, such as anti …
studies have shown that the apelin/APJ system has neuroprotective properties, such as anti …
[HTML][HTML] A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide
R Monastero, D Magro, M Venezia, C Pisano… - Ageing research …, 2023 - Elsevier
ABSTRACT Elabela (ELA), Apela or Toddler peptide is a hormone peptide belonging to the
adipokine group and a component of apelinergic system, discovered in 2013-2014. Given its …
adipokine group and a component of apelinergic system, discovered in 2013-2014. Given its …
The apelin/APJ system as a therapeutic target in metabolic diseases
I Castan-Laurell, B Masri, P Valet - Expert opinion on therapeutic …, 2019 - Taylor & Francis
Introduction: Apelin, a bioactive peptide, is the endogenous ligand of APJ, a G protein-
coupled receptor which is widely expressed in peripheral tissues and in the central nervous …
coupled receptor which is widely expressed in peripheral tissues and in the central nervous …
Elabela gene therapy promotes angiogenesis after myocardial infarction
L Jin, Y Pan, Q Li, J Li, Z Wang - Journal of cellular and …, 2021 - Wiley Online Library
This study was aimed at investigating whether Elabela (ELA) gene therapy can promote
angiogenesis in the treatment of myocardial infarction (MI). The fusion expression plasmid …
angiogenesis in the treatment of myocardial infarction (MI). The fusion expression plasmid …
Elabela may regulate SIRT3‐mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic‐induced myocardial injury
C Li, X Miao, S Wang, Y Liu, J Sun, Q Liu… - Journal of Cellular …, 2021 - Wiley Online Library
Diabetic cardiomyopathy—pathophysiological heart remodelling and dysfunction that occurs
in absence of coronary artery disease, hypertension and/or valvular heart disease—is a …
in absence of coronary artery disease, hypertension and/or valvular heart disease—is a …